CIK 0001321834
- Non-accelerated filer
- Smaller reporting company
Q/C TECHNOLOGIES, INC.
Sign in to watch- Ticker
- QCLS
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 856-848-8698
- Business address
- 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
- Former names
- Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
- 8-K Event Other events
- 8-K Event Material agreement
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Executive or director change
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 8-K Event Material agreement · Executive or director change
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
Page 11 of 12 · 229 filings